[HTML][HTML] Proteomic research in sarcomas–current status and future opportunities

J Burns, CP Wilding, RL Jones, PH Huang - Seminars in Cancer Biology, 2020 - Elsevier
Sarcomas are a rare group of mesenchymal cancers comprising over 70 different
histological subtypes. For the majority of these diseases, the molecular understanding of the …

[HTML][HTML] Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

W Zhang, L Girard, YA Zhang, T Haruki… - … lung cancer research, 2018 - ncbi.nlm.nih.gov
Background Small cell lung cancer (SCLC) is a deadly, high grade neuroendocrine (NE)
tumor without recognized morphologic heterogeneity. However, over 30 years ago we …

The role of the small GTP ase Rab31 in cancer

CEL Chua, BL Tang - Journal of cellular and molecular …, 2015 - Wiley Online Library
Members of the small GTP ase family Rab are emerging as potentially important factors in
cancer development and progression. A good number of Rabs have been implicated or …

Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer

L Wang, Z Liu, R Liang, W Wang, R Zhu, J Li, Z Xing… - Elife, 2022 - elifesciences.org
As the most aggressive tumor, the outcome of pancreatic cancer (PACA) has not improved
observably over the last decade. Anatomy-based TNM staging does not exactly identify …

EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis

H Feng, GY Lopez, CK Kim, A Alvarez… - The Journal of …, 2014 - Am Soc Clin Investig
Aberrant activation of EGFR in human cancers promotes tumorigenesis through stimulation
of AKT signaling. Here, we determined that the discoidina neuropilin-like membrane protein …

Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma

MP Pradhan, A Desai, MJ Palakal - BMC systems biology, 2013 - Springer
Background Epigenetics refers to the reversible functional modifications of the genome that
do not correlate to changes in the DNA sequence. The aim of this study is to understand …

DCBLD2 affects the development of colorectal cancer via EMT and angiogenesis and modulates 5-FU drug resistance

P Xie, FQ Yuan, MS Huang, W Zhang… - Frontiers in Cell and …, 2021 - frontiersin.org
Background: DCBLD2 is highly expressed in various cancers, including colorectal cancer.
DCBLD2 overexpression promotes tumor occurrence, development, and metastasis …

Distinct genome‐wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors

A Tirosh, S Mukherjee, J Lack, SK Gara, S Wang… - Cancer, 2019 - Wiley Online Library
Background Aberrant methylation is a known cause of cancer initiation and/or progression.
There are scant data on the genome‐wide methylation pattern of nonfunctioning pancreatic …

C18 ORF1, a novel negative regulator of transforming growth factor-β signaling

N Nakano, K Maeyama, N Sakata, F Itoh… - Journal of Biological …, 2014 - ASBMB
Transforming growth factor (TGF)-β signaling is deliberately regulated at multiple steps in its
pathway from the extracellular microenvironment to the nucleus. However, how TGF-β …

Circular RNA expression profiles during the differentiation of mouse neural stem cells

Q Yang, J Wu, J Zhao, T Xu, Z Zhao, X Song… - BMC systems biology, 2018 - Springer
Abstract Background Circular RNAs (circRNAs) have recently been found to be expressed in
human brain tissue, and many lines ofevidence indicate that circRNAs play regulatory roles …